VGA039 clinical trials

Study of VGA039 in Healthy Volunteers and Patients With Von Willebrand Disease (VIVID)

This study, called VIVID, is looking at a new medicine for Von Willebrand Disease (VWD) and other bleeding problems. It involves healthy volunteers and people with WVD, testing different ways of giving the medicine, either through a vein or under the skin.